Header

UZH-Logo

Maintenance Infos

Amylin-induced central IL-6 production enhances ventromedial hypothalamic leptin signaling


Le Foll, Christelle; Johnson, Miranda D; Dunn-Meynell, Ambrose; Boyle, Christina N; Lutz, Thomas A; Levin, Barry E (2015). Amylin-induced central IL-6 production enhances ventromedial hypothalamic leptin signaling. Diabetes, 64(5):1621-1631.

Abstract

Amylin acts acutely via the area postrema to reduce food intake and body weight but also interacts with leptin over longer periods of time, possibly via the ventromedial hypothalamus (VMH), to increase leptin signaling and phosphorylation of STAT3 (pSTAT3). We postulated that amylin enhances VMH leptin signaling by inducing IL-6 which then interacts with its gp130 receptor to activate STAT3 signaling and gene transcription downstream of the leptin receptor. We found that components of the amylin receptor (RAMPs1-3, CTR1a,b) are expressed in cultured VMH astrocytes, neurons and microglia, as well as in micropunches of arcuate and ventromedial hypothalamic (VMN) nuclei. Amylin exposure for 5 d increased IL-6 mRNA expression in VMH explants and microglia by 2-3 fold as well as protein abundance in culture supernatants by 5- and 2-fold. Amylin had no similar effects in cultured astrocytes or neurons. In rats, 5 d amylin treatment decreased body weight gain and/or food intake and increased ventromedial nucleus (VMN) IL-6 mRNA. Similar 5 d amylin treatment increased VMN leptin-induced pSTAT3 expression in wild type mice and rats infused with lateral ventricular IgG but not in IL-6 knockout mice or rats infused with ventricular IL-6 antibody. Lateral ventricular infusion of IL-6 antibody also prevented the amylin-induced decrease of body weight gain. These results show that amylin-induced VMH microglial IL-6 production is the likely mechanism by which amylin treatment interacts with VMH leptin signaling to increase its effect on weight loss.

Abstract

Amylin acts acutely via the area postrema to reduce food intake and body weight but also interacts with leptin over longer periods of time, possibly via the ventromedial hypothalamus (VMH), to increase leptin signaling and phosphorylation of STAT3 (pSTAT3). We postulated that amylin enhances VMH leptin signaling by inducing IL-6 which then interacts with its gp130 receptor to activate STAT3 signaling and gene transcription downstream of the leptin receptor. We found that components of the amylin receptor (RAMPs1-3, CTR1a,b) are expressed in cultured VMH astrocytes, neurons and microglia, as well as in micropunches of arcuate and ventromedial hypothalamic (VMN) nuclei. Amylin exposure for 5 d increased IL-6 mRNA expression in VMH explants and microglia by 2-3 fold as well as protein abundance in culture supernatants by 5- and 2-fold. Amylin had no similar effects in cultured astrocytes or neurons. In rats, 5 d amylin treatment decreased body weight gain and/or food intake and increased ventromedial nucleus (VMN) IL-6 mRNA. Similar 5 d amylin treatment increased VMN leptin-induced pSTAT3 expression in wild type mice and rats infused with lateral ventricular IgG but not in IL-6 knockout mice or rats infused with ventricular IL-6 antibody. Lateral ventricular infusion of IL-6 antibody also prevented the amylin-induced decrease of body weight gain. These results show that amylin-induced VMH microglial IL-6 production is the likely mechanism by which amylin treatment interacts with VMH leptin signaling to increase its effect on weight loss.

Statistics

Citations

15 citations in Web of Science®
8 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

63 downloads since deposited on 03 Feb 2015
20 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > Center for Integrative Human Physiology
05 Vetsuisse Faculty > Institute of Veterinary Physiology
05 Vetsuisse Faculty > Institute of Laboratory Animal Science
Dewey Decimal Classification:570 Life sciences; biology
610 Medicine & health
Language:English
Date:2015
Deposited On:03 Feb 2015 15:29
Last Modified:08 Dec 2017 09:56
Publisher:American Diabetes Association
ISSN:0012-1797
Additional Information:This is an author-created, uncopyedited electronic version of an article accepted for publication in Diabetes. The American Diabetes Association (ADA), publisher of Diabetes, is not responsible for any errors or omissions in this version of the manuscript or any version derived from it by third parties. The definitive publisher-authenticated version will be available in a future issue of Diabetes in print and online at http://diabetes.diabetesjournals.org.
Free access at:PubMed ID. An embargo period may apply.
Publisher DOI:https://doi.org/10.2337/db14-0645
PubMed ID:25409701

Download

Download PDF  'Amylin-induced central IL-6 production enhances ventromedial hypothalamic leptin signaling'.
Preview
Content: Accepted Version
Filetype: PDF
Size: 1MB
View at publisher
Download PDF  'Amylin-induced central IL-6 production enhances ventromedial hypothalamic leptin signaling'.
Preview
Content: Accepted Version
Filetype: PDF
Size: 991kB